Conclusions on stockpiling of antiviral drugs challenged.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 52 print issues and online access
$199.00 per year
only $3.83 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
References
Jefferson, T. et al. Neuraminidase Inhibitors for Preventing and Treating Influenza in Healthy Adults and Children (Review) (Wiley, 2014).
Jefferson, T. et al. Br. Med. J. 348, g2545 (2014).
Heneghan, C. J. et al. Br. Med. J. 348, g2547 (2014).
Muthuri, S. G. Lancet Resp. Med. http://dx.doi.org/10.1016/S2213-2600(14)70041-4 (2014).
Related links
Related links
Related links in Nature Research
Report disputes benefit of stockpiling Tamiflu 2014-Apr-10
Drug-company data vaults to be opened 2013-Mar-27
Drugs: Lines of defence 2011-Dec-07
Flu experts rebut conflict claims 2010-Jun-08
Cheaper approaches to flu divide researchers 2007-Aug-29
Structural biology: Antiviral drugs fit for a purpose 2006-Aug-16
Avian flu special: What's in the medicine cabinet? 2005-May-25
Related external links
Rights and permissions
About this article
Cite this article
Butler, D. Tamiflu report comes under fire. Nature 508, 439–440 (2014). https://doi.org/10.1038/508439a
Published:
Issue date:
DOI: https://doi.org/10.1038/508439a